Pediatric ALL, B Cell
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Blinatumomab in Pediatric B-cell Acute Lymphoblastic Leukemia (ALL) With Minimal Residual Disease (MRD) (NCT04604691) | Seoul National University Hospital | 2022-02-18 |
Track Pediatric ALL, B Cell automatically
Every clearance here is in the API, with alerts when new ones post.